Search for: "TEVA USA, INC."
Results 581 - 600
of 646
Sort by Relevance
|
Sort by Date
6 Aug 2009, 11:24 pm
USA, Inc., 566 F.3d 989, 996-97 (Fed. [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
24 Jul 2009, 1:49 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense. [read post]
17 Jul 2009, 1:43 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense". [read post]
28 Jun 2009, 3:08 pm
• Defendants: Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
21 May 2009, 5:18 pm
Teva Pharmaceuticals USA, Inc., P&G sought to prove the date of invention of risedronate - the active ingredient of P&G's osteoporosis drug Actonel ®. [read post]
18 May 2009, 7:00 am
USA, Inc. after the jump. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
14 May 2009, 6:35 pm
Teva Pharmaceuticals USA, Inc., No. 08-1039 (Fed. [read post]
13 May 2009, 9:50 pm
After Defendant-Appellant Teva Pharmaceuticals USA, Inc. notified P&G of its intent to market a generic version of... [read post]
24 Apr 2009, 1:04 am
TEVA PHARMACEUTICALS USA, INC., 1-06-cv-01017 (INSD April 22, 2009, Order) [read post]
25 Mar 2009, 10:00 pm
Teva Pharmaceuticals, USA, 2009 WL 703274 (N.D. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
24 Feb 2009, 2:22 pm
USA, Inc., No. 2009–1071 (Fed. [read post]
22 Jan 2009, 2:06 am
Wyeth, Inc., 168 Cal. [read post]
12 Dec 2008, 8:42 am
USA, Inc., 347 F.3d 1367, 1369 (Fed. [read post]
11 Dec 2008, 10:30 pm
(DRL); and Teva Pharmaceuticals USA, Inc. [read post]
9 Dec 2008, 8:35 am
USA, Inc., 1-06-cv-01017 (INSD December 5, 2008, Order). [read post]
